Overview


According to FutureWise analysis the market for Alopecia Areata in 2023 is US$ 3.16 billion, and is expected to reach US$ 5.16 billion by 2031 at a CAGR of 6.30%.

Alopecia areata is a type of autoimmune disorder that can cause sudden hair loss in circular or oval patches on various parts of the body. This can include the scalp, eyebrows, eyelashes, and other areas. Although the exact cause of the condition is not fully understood, a combination of environmental and genetic factors is believed to contribute to it. While there is no known cure for alopecia areata, several treatment options are available to manage the condition, including corticosteroids applied to the skin, minoxidil, and topical immunotherapy, among others.

It is important to note that alopecia areata can impact a person's emotional well-being, self-esteem, and body image. Therefore, support groups and counselling can offer emotional support to those affected by the condition. If you suspect you have alopecia areata or are experiencing hair loss, it is advisable to seek the advice of a healthcare professional, such as a dermatologist, who can provide accurate diagnosis, discuss treatment options, and offer guidance on managing the emotional impact of the condition.

FutureWise Market Research has published a report that provides an insightful analysis of alopecia areata market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that alopecia areata market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Johnson & Johnson Services, Inc.
  • Mylan N.V.
  • Encore Dermatology, Inc.
  • Galderma
  • Silvergate Pharmaceuticals
  • Hikma Pharmaceuticals PLC.
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc.
  • Perrigo Company PLC.
  • Zydus Pharmaceuticals
  • MerckCo., Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)
 

Recent developments by key players in the Alopecia Areata Market

  • In March 2023, A global pharmaceutical company, Sun Pharmaceuticals Industries Ltd., has announced the presentation of phase 3 clinical trial data for deuruxolitinib. This medication comes in the form of an oral drug and has been specifically designed to help improve scalp hair regrowth in patients who have alopecia areata.

The market for alopecia areata is experiencing a surge driven by several factors. One of the primary drivers is the increasing incidence of autoimmune diseases, including alopecia areata. The emergence of advanced treatment options is also contributing to the growth of the market. With the progress of technology, innovative therapies are being developed to address the needs of patients suffering from this condition. However, the market still faces significant challenges, particularly in the need for more efficient and effective therapies.
To overcome these hurdles and improve patient outcomes, ongoing research and development initiatives are being undertaken. These initiatives seek to identify new therapeutic options that can address the underlying causes of alopecia areata. Additionally, efforts are being made to improve the delivery mechanisms for these therapies, making them more accessible and convenient for patients. Overall, the alopecia areata market is poised for continued growth as researchers and healthcare providers work together to address the needs of patients suffering from this condition. 

By Type

  • Patchy Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • Diffuse Alopecia Areata
  • Ophiasis Alopecia
  • Others

By Diagnosis

  • Trichoscopy
  • Skin Biopsy
  • Others

By Treatment

  • Medical Treatments
  • Natural Treatment
  • Others

By Route of Administration

  • Oral
  • Topical
  • Parenteral
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

By End-Users

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The dominance of North America in the alopecia areata market can be attributed to the growing prevalence of autoimmune diseases in the region. Autoimmune diseases, including alopecia areata, are becoming increasingly common, leading to a larger patient pool seeking treatment. The availability of advanced healthcare facilities and a well-established healthcare system in North America also contribute to the market's growth. Moreover, the region's higher healthcare expenditure allows for greater investment in research and development, leading to the development of innovative therapies and treatments for alopecia areata. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Alopecia Areata Market By Type, By Diagnosis, By Treatment, By Route of Administration, By Distribution Channel, By End-Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Alopecia Areata Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Alopecia Areata Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Alopecia Areata Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Alopecia Areata Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Patchy Alopecia Areata
        2. Alopecia Totalis
        3. Alopecia Universalis
        4. Diffuse Alopecia Areata
        5. Ophiasis Alopecia
        6. Others

  • 8.   Alopecia Areata Market, By Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Trichoscopy
        2. Skin Biopsy
        3. Others

  • 9.   Alopecia Areata Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Medical Treatments
        2. Natural Treatment
        3. Others

  • 10.   Alopecia Areata Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Oral
        2. Topical
        3. Parenteral
        4. Others

  • 11.   Alopecia Areata Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Others

  • 12.   Alopecia Areata Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals
        2. Specialty Clinics
        3. Others

  • 13.   North America Alopecia Areata Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.   Latin America Alopecia Areata Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.   Europe Alopecia Areata Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.   Asia Pacific Alopecia Areata Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 17.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 19.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    • 1. Johnson & Johnson Services, Inc.
               1.1. Company Overview
               1.2. Product Portfolio
               1.3. SWOT Analysis
               1.4. Financial Overview
               1.5. Strategic Overview
         2. Mylan N.V.
               2.1. Company Overview
               2.2. Product Portfolio
               2.3. SWOT Analysis
               2.4. Financial Overview
               2.5. Strategic Overview
         3. Encore Dermatology, Inc.
               3.1. Company Overview
               3.2. Product Portfolio
               3.3. SWOT Analysis
               3.4. Financial Overview
               3.5. Strategic Overview
         4. Galderma
               4.1. Company Overview
               4.2. Product Portfolio
               4.3. SWOT Analysis
               4.4. Financial Overview
               4.5. Strategic Overview
         5. Silvergate Pharmaceuticals
               5.1. Company Overview
               5.2. Product Portfolio
               5.3. SWOT Analysis
               5.4. Financial Overview
               5.5. Strategic Overview
         6. Hikma Pharmaceuticals PLC.
               6.1. Company Overview
               6.2. Product Portfolio
               6.3. SWOT Analysis
               6.4. Financial Overview
               6.5. Strategic Overview      
         7. Sun Pharmaceutical Industries Ltd.
               7.1. Company Overview
               7.2. Product Portfolio
               7.3. SWOT Analysis
               7.4. Financial Overview
               7.5. Strategic Overview
         8. GlaxoSmithKline plc.
               8.1. Company Overview
               8.2. Product Portfolio
               8.3. SWOT Analysis
               8.4. Financial Overview
               8.5. Strategic Overview
         9. Perrigo Company PLC.
               9.1. Company Overview
               9.2. Product Portfolio
               9.3. SWOT Analysis
               9.4. Financial Overview
               9.5. Strategic Overview
         10.Zydus Pharmaceuticals
               10.1. Company Overview
               10.2. Product Portfolio
               10.3. SWOT Analysis
               10.4. Financial Overview
               10.5. Strategic Overview
         11.Merck & Co., Inc.
               11.1. Company Overview
               11.2. Product Portfolio
               11.3. SWOT Analysis
               11.4. Financial Overview
               11.5. Strategic Overview

  • 20.   Pre and Post COVID-19 Impact

    • 1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations

  • 21.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

Related Market

Alopecia Drugs Market

Read More

Alopecia Treatment Market

Read More

Alopecia Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11